![Jaume Pons](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jaume Pons
Founder at
Alx Oncology Ltd.
Net worth: 954 808 $ as of 2026-08-30
Profile
Jaume Pons is the founder of ALX Oncology Ltd., founded in 2015, serving as President, Chief Executive Officer & Director.
Dr. Pons was the founder of ALX Oncology Holdings, Inc., founded in 2015, and served as President & Chief Scientific Officer from 2024 to 2025.
Dr. Pons is the founder of Tallac Therapeutics, Inc., founded in 2018, serving as Director.
Dr. Pons is also the founder of ALX Oncology, Inc...
Dr. Pons currently serves as Director at Alexo Therapeutics International.
Dr. Pons currently serves as Director at Sirpant Therapeutics.
Dr. Pons currently serves as Scientific Advisor at LSV Capital Management LLC.
Formerly, Dr. Pons was Chief Scientific Officer at Pfizer Inc. from 2007 to 2015.
Formerly, Dr. Pons was Chief Scientific Officer at Rinat Neuroscience Corp.
from 2007 to 2015.
Formerly, Dr. Pons was Venture Partner at venBio Partners LLC.
Dr. Pons completed graduate studies at the University of California, Berkeley in 1999.
Dr. Pons completed undergraduate, graduate, and doctorate degrees at the Autonomous University of Barcelona.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 494,719 ( 0.36% ) | 954 808 $ | 2026-08-30 |
Jaume Pons active positions
| Companies | Position | Start |
|---|---|---|
Alx Oncology Ltd.
 Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Operates as biotechnology company developing immuno-oncology therapies for cancer | Founder | 2015-03-31 |
Alexo Therapeutics International
 Alexo Therapeutics International Pharmaceuticals: MajorHealth Technology Alexo Therapeutics International develops immune-oncology therapies for cancer. The company is headquartered in South San Francisco, CA. | Director/Board Member | - |
Tallac Therapeutics, Inc.
 Tallac Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in research and development of immunomodulation polynucleotides | Founder | 2017-12-31 |
Sirpant Therapeutics | Director/Board Member | - |
LSV CAPITAL MANAGEMENT LLC
 LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm focuses on healthcare,medicine, consumer, biotech and medtech sectors. It participates in seed, early, later and growth stage capital requirements. | Consultant / Advisor | - |
Former positions of Jaume Pons
| Companies | Position | End |
|---|---|---|
| ALX ONCOLOGY HOLDINGS INC. | Chief Executive Officer | 2023-09-05 |
Rinat Neuroscience Corp.
 Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Chief Tech/Sci/R&D Officer | 2015-01-31 |
| PFIZER INC. | Chief Tech/Sci/R&D Officer | - |
ALX Oncology, Inc.
 ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company which develops therapies for cancers | Chief Executive Officer | - |
| ░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
Training of Jaume Pons
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
74
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Health Technology |
venBio Partners LLC
 venBio Partners LLC Investment ManagersFinance venBio invests in companies located in the United States. The firm focuses on companies operating in the fields of life sciences sectors. It participates in early to late stage transactions. The firm acts as a lead investor. | Finance |
Autonomous University of Barcelona
 Autonomous University of Barcelona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
LSV CAPITAL MANAGEMENT LLC
LSV CAPITAL MANAGEMENT LLC Investment ManagersFinance LSV Capital Management invests in companies located across the globe. The firm focuses on healthcare,medicine, consumer, biotech and medtech sectors. It participates in seed, early, later and growth stage capital requirements. | Finance |
Alx Oncology Ltd.
Alx Oncology Ltd. Pharmaceuticals: MajorHealth Technology Operates as biotechnology company developing immuno-oncology therapies for cancer | Health Technology |
ALX Oncology, Inc.
ALX Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immuno-oncology company which develops therapies for cancers | Health Technology |
Tallac Therapeutics, Inc.
Tallac Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in research and development of immunomodulation polynucleotides | Health Technology |
ALX Oncology Holdings, Inc.
 ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
Alexo Therapeutics International
Alexo Therapeutics International Pharmaceuticals: MajorHealth Technology Alexo Therapeutics International develops immune-oncology therapies for cancer. The company is headquartered in South San Francisco, CA. | Health Technology |
Sirpant Therapeutics |
- Stock Market
- Insiders
- Jaume Pons
